Last updated on June 2020

Osimertinib Plus Savolitinib in EGFRm+/MET+ NSCLC Following Prior Osimertinib

Find a site near you

Start Over

Research Site

Petah Tikva, Israel
  Connect »

Research Site

Kfar Saba, Israel
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.